SCHEMBL28679014

SCHEMBL28679014

CN(c1ccc(Nc2ncc3cccc(-c4ccc(OCCN5CCCC5)cc4)c3n2)cc1)[SH](=O)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 9/20 0.51
JAK3 P52333 9/20 0.51
PTK2 Q05397 6/20 0.51
FGFR1 P11362 3/20 0.50
BRAF P15056 2/20 0.50
BRD4 O60885 4/20 0.48
BRDT Q58F21 2/20 0.48
BRD2 P25440 1/20 0.48
BRD3 Q15059 1/20 0.48
SRC P12931 6/20 0.47
YES1 P07947 4/20 0.47
KDR P35968 4/20 0.47
EPHB4 P54760 4/20 0.47
ABL1 P00519 3/20 0.47
EGFR P00533 3/20 0.47
LCK P06239 2/20 0.47
FYN P06241 2/20 0.47
LYN P07948 2/20 0.47
PDGFRB P09619 2/20 0.47
RPS6KB1 P23443 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18377066 0.89 BRAF (0.60) JAK2JAK3PTK2FGFR1BRAF
SCHEMBL29371925 0.89 BRAF (0.60) JAK2JAK3PTK2FGFR1BRAF
SCHEMBL18377042 0.87 BRAF (0.55) JAK2JAK3PTK2FGFR1BRAF
SCHEMBL29370829 0.87 BRAF (0.55) JAK2JAK3PTK2FGFR1BRAF
SCHEMBL18376830 0.85 JAK2 (0.68) JAK2JAK3PTK2FGFR1BRAF
SCHEMBL18376808 0.84 JAK2 (0.57) JAK2JAK3PTK2FGFR1BRAF
SCHEMBL18376653 0.84 JAK2 (0.57) JAK2JAK3PTK2FGFR1BRAF
SCHEMBL28681322 0.84 MAPK10 (0.56) JAK2PTK2BRAFBRD4ABL1
SCHEMBL28695565 0.83 EGFR (0.44) JAK2JAK3PTK2YES1EPHB4
SCHEMBL18376804 0.83 JAK2 (0.57) JAK2JAK3PTK2FGFR1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 CN disclosed